Trial Profile
Prospective study evaluating the effect of intravitreal injection of bevacizumab on intraocular pressure in patients with macular oedema or choroidal neovascularization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Choroidal neovascularisation; Retinal oedema
- Focus Therapeutic Use
- 11 Feb 2016 New trial record